This inventor holds 2 USPTO granted patents. Top assignee: Huyabio International, LLC. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Jay Mason: Innovator in Cardiac Treatment
Introduction
Jay Mason is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cardiac treatment through his innovative work. With a total of 2 patents, Mason is dedicated to improving patient outcomes in acute atrial fibrillation.
Latest Patents
Mason's latest patents focus on the administration of sulcardine for the treatment of acute atrial fibrillation. The patents detail compositions and methods for administering sulcardine to subjects in need of this treatment. His work aims to provide effective solutions for managing this serious cardiac condition.
Career Highlights
Mason is currently associated with Huyabio International, LLC, where he continues to develop and refine his innovative ideas. His career is marked by a commitment to advancing medical treatments and improving the quality of life for patients suffering from heart-related issues.
Collaborations
Mason collaborates with esteemed colleagues, including Robert Goodenow and Waldemar Radziszewski. These partnerships enhance the research and development efforts within his field, fostering a collaborative environment for innovation.
Conclusion
Jay Mason's contributions to cardiac treatment through his patents and collaborations highlight his dedication to medical innovation. His work continues to pave the way for advancements in the treatment of acute atrial fibrillation.